M C Manara - JoVE Visualize

Showing results (21-30 of 34) with videos related to

Pageof 4

Sort By:

Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|February 24, 2001

Murine model for skeletal metastases of Ewing's sarcomaK Scotlandi, S Benini, M C Manara, et al.

International Journal of Oncology|January 26, 1999

Relationship between P-glycoprotein expression and p53 status in high-grade osteosarcomaM Serra, D Maurici, K Scotlandi, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2008

Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteosarcomaI Scionti, F Michelacci, M Pasello, et al.

International Journal of Oncology|November 8, 2005

The molecular mechanisms responsible for resistance to ET-743 (Trabectidin; Yondelis) in the Ewing's sarcoma cell line, TC-71M C Manara, S Perdichizzi, M Serra, et al.

Bone|March 10, 2000

Reversal of malignant phenotype in human osteosarcoma cells transduced with the alkaline phosphatase geneM C Manara, N Baldini, M Serra, et al.

Cancer Research|October 4, 2000

CD99 engagement: an effective therapeutic strategy for Ewing tumorsK Scotlandi, N Baldini, V Cerisano, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003

Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cellsM Serra, G Reverter-Branchat, D Maurici, et al.

Oncogene|May 2, 2007

CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activityK Scotlandi, M Zuntini, M C Manara, et al.

Oncogene|May 7, 2013

CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activityC Zucchini, M C Manara, R S Pinca, et al.

Oncogene|December 1, 2015

CD99 regulates neural differentiation of Ewing sarcoma cells through miR-34a-Notch-mediated control of NF-κB signalingS Ventura, D N T Aryee, F Felicetti, et al.

Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:

Pageof 4

Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|February 24, 2001

Murine model for skeletal metastases of Ewing's sarcomaK Scotlandi, S Benini, M C Manara, et al.

International Journal of Oncology|January 26, 1999

Relationship between P-glycoprotein expression and p53 status in high-grade osteosarcomaM Serra, D Maurici, K Scotlandi, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2008

Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteosarcomaI Scionti, F Michelacci, M Pasello, et al.

International Journal of Oncology|November 8, 2005

The molecular mechanisms responsible for resistance to ET-743 (Trabectidin; Yondelis) in the Ewing's sarcoma cell line, TC-71M C Manara, S Perdichizzi, M Serra, et al.

Bone|March 10, 2000

Reversal of malignant phenotype in human osteosarcoma cells transduced with the alkaline phosphatase geneM C Manara, N Baldini, M Serra, et al.

Cancer Research|October 4, 2000

CD99 engagement: an effective therapeutic strategy for Ewing tumorsK Scotlandi, N Baldini, V Cerisano, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003

Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cellsM Serra, G Reverter-Branchat, D Maurici, et al.

Oncogene|May 2, 2007

CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activityK Scotlandi, M Zuntini, M C Manara, et al.

Oncogene|May 7, 2013

CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activityC Zucchini, M C Manara, R S Pinca, et al.

Oncogene|December 1, 2015

CD99 regulates neural differentiation of Ewing sarcoma cells through miR-34a-Notch-mediated control of NF-κB signalingS Ventura, D N T Aryee, F Felicetti, et al.

Pageof 4